Woodmont Investment Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.6M Buy
22,183
+234
+1% +$239K 1.45% 16
2026
Q1
$20.2M Buy
21,949
+1,129
+5% +$1.14M 1.24% 23
2025
Q4
$22.4M Buy
20,820
+103
+0.5% +$98.5K 1.4% 16
2025
Q3
$15.8M Buy
20,717
+807
+4% +$601K 1.05% 26
2025
Q2
$15.5M Buy
19,910
+6,933
+53% +$5.39M 1.02% 23
2025
Q1
$10.7M Buy
12,977
+2,290
+21% +$1.91M 0.77% 31
2024
Q4
$8.25M Buy
10,687
+5,856
+121% +$4.85M 0.61% 39
2024
Q3
$4.28M Sell
4,831
-41
-0.8% -$36.9K 0.32% 63
2024
Q2
$4.41M Buy
4,872
+37
+0.8% +$29.6K 0.36% 56
2024
Q1
$3.76M Buy
4,835
+74
+2% +$52.7K 0.32% 62
2023
Q4
$2.78M Buy
4,761
+237
+5% +$138K 0.26% 77
2023
Q3
$2.43M Sell
4,524
-92
-2% -$47.4K 0.26% 81
2023
Q2
$2.16M Sell
4,616
-415
-8% -$174K 0.22% 84
2023
Q1
$1.73M Buy
5,031
+310
+7% +$105K 0.18% 99
2022
Q4
$1.73M Hold
4,721
0.2% 98
2022
Q3
$1.53M Sell
4,721
-50
-1% -$15.8K 0.19% 99
2022
Q2
$1.55M Buy
4,771
+200
+4% +$60K 0.19% 101
2022
Q1
$1.31M Sell
4,571
-625
-12% -$161K 0.15% 112
2021
Q4
$1.44M Hold
5,196
0.18% 100
2021
Q3
$1.2M Sell
5,196
-30
-0.6% -$7.4K 0.17% 101
2021
Q2
$1.2M Hold
5,226
0.19% 95
2021
Q1
$976K Buy
5,226
+15
+0.3% +$2.93K 0.17% 102
2020
Q4
$880K Buy
5,211
+430
+9% +$64.2K 0.16% 102
2020
Q3
$708K Sell
4,781
-50
-1% -$7.74K 0.15% 109
2020
Q2
$793K Sell
4,831
-75
-2% -$11.5K 0.19% 100
2020
Q1
$681K Sell
4,906
-325
-6% -$44.7K 0.19% 101
2019
Q4
$688K Hold
5,231
0.16% 112
2019
Q3
$585K Sell
5,231
-200
-4% -$22.3K 0.14% 118
2019
Q2
$602K Buy
5,431
+325
+6% +$38.3K 0.15% 115
2019
Q1
$663K Sell
5,106
-750
-13% -$91.2K 0.17% 114
2018
Q4
$678K Sell
5,856
-60
-1% -$6.7K 0.19% 106
2018
Q3
$635K Sell
5,916
-75
-1% -$7.5K 0.17% 110
2018
Q2
$511K Sell
5,991
-250
-4% -$20.5K 0.14% 118
2018
Q1
$483K Sell
6,241
-264
-4% -$21.3K 0.13% 126
2017
Q4
$549K Hold
6,505
0.14% 129
2017
Q3
$556K Buy
6,505
+89
+1% +$7.3K 0.15% 124
2017
Q2
$528K Hold
6,416
0.15% 123
2017
Q1
$472K Hold
6,416
0.14% 131
2016
Q4
$472K Buy
6,416
+339
+6% +$25.2K 0.14% 135
2016
Q3
$488K Sell
6,077
-42
-0.7% -$3.36K 0.14% 134
2016
Q2
$482K Sell
6,119
-252
-4% -$19K 0.14% 138
2016
Q1
$459K Hold
6,371
0.14% 132
2015
Q4
$537K Sell
6,371
-250
-4% -$20.7K 0.16% 129
2015
Q3
$554K Sell
6,621
-200
-3% -$16.9K 0.17% 128
2015
Q2
$569K Sell
6,821
-100
-1% -$7.62K 0.16% 127
2015
Q1
$503K Sell
6,921
-800
-10% -$57K 0.16% 127
2014
Q4
$533K Hold
7,721
0.16% 128
2014
Q3
$501K Sell
7,721
-250
-3% -$15.8K 0.14% 148
2014
Q2
$496K Sell
7,971
-41
-0.5% -$2.45K 0.14% 151
2014
Q1
$472K Sell
8,012
-200
-2% -$11.2K 0.14% 152
2013
Q4
$419K Buy
8,212
+2,175
+36% +$109K 0.13% 150
2013
Q3
$304K Buy
6,037
+350
+6% +$18.3K 0.11% 142
2013
Q2
$279K Buy
+5,687
New +$309K 0.09% 174

Other funds holding LLY

Woodmont Investment Counsel's LLY Position: Q2 2026 in Review

Woodmont Investment Counsel increased its Eli Lilly (LLY) stake by 1.1% in Q2 2026, buying an estimated $239K and bringing the position to 22,183 shares worth $26.6M. The position accounts for 1.45% of the portfolio, ranked #16.

Woodmont Investment Counsel first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 2,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Woodmont Investment Counsel held 22,183 shares of Eli Lilly worth $26.6M as of Q2 2026.
  • Woodmont Investment Counsel bought 234 Eli Lilly shares in Q2 2026, an estimated $239K.
  • Eli Lilly made up 1.45% of Woodmont Investment Counsel's portfolio in Q2 2026, its #16 holding.
  • Woodmont Investment Counsel first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 2,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Woodmont Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.